Join Biovie’s Exclusive Live Investor Webinar and Q&A Session on December 9
Join Biovie's Exclusive Live Investor Webinar and Q&A Session on December 9 GlobeNewswire November 19, 2025 CARSON CITY, Nev., Nov. 19, 2025 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, is pleased to invite investors to a webinar on December […]